Saad Mark E
SEC insider (Form 3/4/5 filer). CIK 0001295913. Director at Axsome Therapeutics, Inc. (AXSM). 13 reported Form 4/5 transactions since Sep 2024; latest on Jun 8, 2026. Located in NEW YORK, NY.
Companies Saad Mark E has filed insider reports for
- Axsome Therapeutics, Inc. (AXSM): Director
Saad Mark E
CIK: 0001295913
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Axsome Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Jun 8, 2026AXSM
Axsome Therapeutics, Inc.
ExerciseDirect1.4K shares- - Jun 5, 2026AXSM
Axsome Therapeutics, Inc.
AwardDirectRestricted Stock Units
1.7K shares- - Dec 31, 2025AXSM
Axsome Therapeutics, Inc.
SaleDirect6.2K shares at avg. $165.18$1.0M - Dec 31, 2025AXSM
Axsome Therapeutics, Inc.
ExerciseDirect31.3K shares at avg. $4.95$155K - Dec 31, 2025AXSM
Axsome Therapeutics, Inc.
SaleDirect31.3K shares at avg. $165.18$5.2M - Dec 31, 2025AXSM
Axsome Therapeutics, Inc.
ExerciseDirect6.2K shares at avg. $8.02$50K - Sep 5, 2025AXSM
Axsome Therapeutics, Inc.
ExerciseDirect9.1K shares at avg. $9.00$82K - Sep 5, 2025AXSM
Axsome Therapeutics, Inc.
SaleDirect9.1K shares at avg. $125.07$1.1M - Jun 6, 2025AXSM
Axsome Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
3.2K shares- - Jun 6, 2025AXSM
Axsome Therapeutics, Inc.
AwardDirectRestricted Stock Units
1.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 8, 2026 | AXSM Axsome Therapeutics, Inc. | Exercise | 1,429 | - | $0 | Direct |
| Jun 5, 2026 | AXSM Axsome Therapeutics, Inc. | Award Restricted Stock Units | 1,721 | - | - | Direct |
| Dec 31, 2025 | AXSM Axsome Therapeutics, Inc. | Sale | 6,231 | $165.18 | $1,029,237 | Direct |
| Dec 31, 2025 | AXSM Axsome Therapeutics, Inc. | Exercise | 31,346 | $4.95 | $155,163 | Direct |
| Dec 31, 2025 | AXSM Axsome Therapeutics, Inc. | Sale | 31,346 | $165.18 | $5,177,732 | Direct |
| Dec 31, 2025 | AXSM Axsome Therapeutics, Inc. | Exercise | 6,231 | $8.02 | $49,973 | Direct |
| Sep 5, 2025 | AXSM Axsome Therapeutics, Inc. | Exercise | 9,127 | $9.00 | $82,143 | Direct |
| Sep 5, 2025 | AXSM Axsome Therapeutics, Inc. | Sale | 9,127 | $125.07 | $1,141,514 | Direct |
| Jun 6, 2025 | AXSM Axsome Therapeutics, Inc. | Award Stock Option (Right to Buy) | 3,166 | - | - | Direct |
| Jun 6, 2025 | AXSM Axsome Therapeutics, Inc. | Award Restricted Stock Units | 1,429 | - | - | Direct |
1-10 of 13 transactions